ALFA Finder| Revenue growth | 12% for standalone Aster; 14% proforma merged entity for FY26. |
|---|---|
| Margins | Merged entity EBITDA margins improved to 21.7% (116 bps YoY). |
| Demand visibility | Strong; patient volumes grew 12% in Q4FY26. |
| Management confidence | High; citing cash-neutral merger and significant synergy potential. |
Growth
FY26 proforma revenue up 14% to ₹9,273 Cr; Operating EBITDA grew 21% to ₹2,013 Cr with 21.7% margins.
Outlook
Targeting expansion to ~15,068 beds via internal accruals; merger expected to be EPS accretive from year 1.
Risks
Subject to NCLT and regulatory approvals; integration risks of combined brands and geography.
Earnings Call filed with NSE, NSE: ASTERDM. Summary written with AI assistance from the document.
Aster DM Healthcare Ltd: key numbers
- Share price
- ₹724.20
- Market cap
- ₹63,127 Cr
- Revenue (annual)
- ₹4,643 Cr
- Net profit (annual)
- ₹388.1 Cr
- P/E (TTM)
- 134.1×Sector 54.5×
- Promoter holding
- 53.79%+13.40% QoQ
- FII holding
- 12.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aster DM Healthcare Ltd
All →Aster DM Quality Care Adverse Business Impact
Aster DM Quality Care terminated its O&M and Medical Services agreements with DM Education and Research Foundation, ceasing related hospital operations. The Aster Wayanad hospital contributed 1.20% of turnover; no consideration was received.
Aster DM Quality Care Acquisition Worth ₹102.5 Cr
Aster DM will acquire Sri Sainatha Hospitals by converting a Rs 102.46 Crore loan into equity. The related-party deal completes within three months.
- Value
- ₹102.5 Cr
- Execution
- Within 3 months
Aster DM Quality Care Capital Structure Change
Aster DM approved converting a Rs 102.46 Crore subsidiary loan into equity shares. It also approved terminating DMERF operations and medical services agreements.
- Value
- ₹102.5 Cr
- Execution
- Within 3 months
Aster DM Quality Care Results Update
Aster DM Quality Care released a press release on its Q2 FY27 unaudited results, reporting revenue up 19% to Rs 2,829 crore. Normalised PAT rose 34% to Rs 281 crore.
Aster DM Quality Care Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 2,829 Cr (+19% YoY), Op EBITDA INR 678 Cr (+25%), margin 24.0% (+111 bps), normalised PAT INR 281 Cr (+34%). Post-merger synergies and bed expansion to 15,070.
Aster DM Quality Care Q2 FY27 Results: Net Profit ₹322.4 Cr, Up 165.8% YoY
Aster DM Quality Care Ltd reported revenue from operations of ₹2,829 Cr (+136.3% YoY) and net profit of ₹322.4 Cr (+165.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹322.4 Cr · +165.8% YoY